Brain stem cell implant trial hopes to ease Parkinson's symptoms
Disease control
Recruiting now
This early-stage trial tests whether implanting special dopamine-making stem cells into the brain is safe for people with Parkinson's disease. About 12 participants aged 45 to 75 will receive the cells during a surgical procedure. The study will monitor side effects and check for…
Phase: PHASE1, PHASE2 • Sponsor: Kenai Therapeutics • Aim: Disease control
Last updated May 06, 2026 16:01 UTC